Neurobiological Technologies, Inc.
Neurobiological Technologies, Inc. (NTII) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ntii · pe ratio · data through Jun 30, 2010
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Neurobiological Technologies, Inc. (NTII) measures how much investors pay for each dollar of the company's trailing earnings. NTII's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.12. −100.0% discount vs 5Y avg 19.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2010-06-30
PE Ratio History
1994 – 2010 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Neurobiological Technologies, Inc.You NTII | $0M | 0.00x | — | $0.12 |
 Anthera Pharmaceuticals, Inc. ANTH | $0M | N/A | — | -$1.65 |
 Comera Life Sciences Holdings, Inc. CMRA | $0M | N/A | — | -$1.72 |
 Cotinga Pharmaceuticals Inc. COTQF | $0M | N/A | — | -$0.09 |
 ForU Holdings, Inc. FORU | $0M | N/A | — | -$8.27 |
 GlobeImmune, Inc. GBIM | $0M | N/A | — | -$0.48 |
 OncoVista Innovative Therapies, Inc. OVIT | $0M | N/A | — | -$0.12 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2010-06-30Latest FY2010 | — | $0.00 | — | |
2009-06-30 FY2009 | 5.82x | $0.12 | — | |
2008-06-30 FY2008 | — | $-0.84 | — | |
2007-06-30 FY2007 | — | $-3.26 | — | |
2006-06-30 FY2006 | — | $-6.84 | — | |
2005-06-30 FY2005 | — | $-6.59 | — | |
2004-06-30 FY2004 | — | $-0.61 | — | |
2003-06-30 FY2003 | — | $-1.04 | — | |
2002-06-30 FY2002 | — | $-1.70 | — | |
2001-06-30 FY2001 | 32.78x | $0.67 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Neurobiological Technologies, Inc. (NTII) measures how much investors pay for each dollar of the company's trailing earnings. NTII's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.12.
Frequently asked questions
NTII pe ratio · 6 questionsNTII's current PE ratio is 0.00x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.12. Data sourced from Financial Modeling Prep via NTII's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Neurobiological Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09